Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Carcinoma

Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

820 public trials 196 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Carcinoma trial results

Active, Not Recruiting

A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC

NCT06745323

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut Plainville, Connecticut, United States
  • AdventHealth Hematology and Oncology Orlando, Florida, United States
  • City of Hope Chicago Rockford, Illinois, United States
View all 78 locations
View Trial Details
Active, Not Recruiting

Study of Oral MRT-2359 in Selected Cancer Patients

NCT05546268

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +38 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Kansas Cancer Center Lawrence, Kansas, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

NCT05280470

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • The Cancer Specialists, Llc Jacksonville, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View all 58 locations
View Trial Details
Active, Not Recruiting

A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)

NCT04471727

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +26 more
Locations
  • Cedar-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer

NCT04665856

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Beijing Chest Hospital Beijing, China
  • the First Affiliated Hospital of Bengbu Medical College Bengbu, China
  • the First Hospital of Jilin University Changchun, China
View all 16 locations
View Trial Details

Related conditions